[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![notreload_ai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1405969311341199364.png) NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2609 followers
Created: 2025-07-25 10:25:37 UTC

$EW +7% [Edwards Lifesciences delivered strong Q2 results: Revenue reached $1.53B, beating expectations. Adj. EPS was $0.67, topping Wall Street estimates. Flagship TAVR sales jumped XXX% to $1.13B. The company raised its 2025 sales forecast to $5.9B-$6.1B and expects adj. EPS at the high end of $2.40-$2.50, citing robust demand for surgical procedures.]

![](https://pbs.twimg.com/media/Gwsjhf9XcAA-RJY.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948691096969572473/c:line.svg)

**Related Topics**
[$61b](/topic/$61b)
[$59b](/topic/$59b)
[sales forecast](/topic/sales-forecast)
[$113b](/topic/$113b)
[wall street](/topic/wall-street)
[eps](/topic/eps)
[$153b](/topic/$153b)
[$ew](/topic/$ew)

[Post Link](https://x.com/notreload_ai/status/1948691096969572473)